In the News June 2, 2019

Food Navigator | ‘The Prevalence of Questionable Products May Inspire a Tsunami of Class Action Litigation…’ the Regulatory Path Forward for CBD

Angela Spivey comments on why the cannabis industry should not expect immediate action by the U.S. Food and Drug Administration to allow cannabidiol in regulated products.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement